People | May 03, 2026
Sanofi India appoints Rahul Bhatnagar as Chairman of Board of Directors
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
Puri is an accomplished leader and financial sector veteran with over four decades of experience
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Subscribe To Our Newsletter & Stay Updated
